Stage IA and IIA supradiaphragmatic Hodgkin's disease: Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation

P. Mauch, N. Tarbell, H. Weinstein, B. Silver, T. Goffman, R. Osteen, A. Zajac, C. N. Coleman, G. Canellos, D. Rosenthal

Research output: Contribution to journalArticle

Abstract

A total of 315 pathologically staged (PS) patients with IA and IIA Hodgkin's disease (HD) were treated with mantle and paraaortic irradiation, and evaluated for freedom-from-first relapse (FFR), survival, prognostic factors, and long-term complications. The 14-year actuarial FFR and survival were 82% and 93%, respectively, with a median follow-up time of 9 years. Mediastinal size was the only factor that predicted for a lower FFR, P <.0001. Forty-nine patients have developed recurrent HD. Thirty-six patients are disease-free following retreatment and only 13 patients have died of HD. Patients with mixed cellularity (MC) histology were more likely to relapse below the diaphragm (11%) as compared with patients with nodular sclerosis (NS) (5.1%) or lymphocyte predominant (LP) (3.6%) histology. These relapses were often associated with bulky pelvic nodal adenopathy, and salvage treatment with chemotherapy alone often failed to control recurrent disease. Alternative diagnostic and therapeutic recommendations are presented for three patients. Thyroid abnormalities represented the most common long-term complication with an actuarial risk at 16 years of 37%. Major complications were rare. Mantle and paraaortic irradiation is associated with a high FFR and a low risk of complications and should remain standard treatment for early-stage HD.

Original languageEnglish (US)
Pages (from-to)1576-1583
Number of pages8
JournalJournal of Clinical Oncology
Volume6
Issue number10
StatePublished - 1988
Externally publishedYes

Fingerprint

Hodgkin Disease
Recurrence
Histology
Salvage Therapy
Retreatment
Survival
Sclerosis
Diaphragm
Thyroid Gland
Lymphocytes
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mauch, P., Tarbell, N., Weinstein, H., Silver, B., Goffman, T., Osteen, R., ... Rosenthal, D. (1988). Stage IA and IIA supradiaphragmatic Hodgkin's disease: Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. Journal of Clinical Oncology, 6(10), 1576-1583.

Stage IA and IIA supradiaphragmatic Hodgkin's disease : Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. / Mauch, P.; Tarbell, N.; Weinstein, H.; Silver, B.; Goffman, T.; Osteen, R.; Zajac, A.; Coleman, C. N.; Canellos, G.; Rosenthal, D.

In: Journal of Clinical Oncology, Vol. 6, No. 10, 1988, p. 1576-1583.

Research output: Contribution to journalArticle

Mauch, P, Tarbell, N, Weinstein, H, Silver, B, Goffman, T, Osteen, R, Zajac, A, Coleman, CN, Canellos, G & Rosenthal, D 1988, 'Stage IA and IIA supradiaphragmatic Hodgkin's disease: Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation', Journal of Clinical Oncology, vol. 6, no. 10, pp. 1576-1583.
Mauch, P. ; Tarbell, N. ; Weinstein, H. ; Silver, B. ; Goffman, T. ; Osteen, R. ; Zajac, A. ; Coleman, C. N. ; Canellos, G. ; Rosenthal, D. / Stage IA and IIA supradiaphragmatic Hodgkin's disease : Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. In: Journal of Clinical Oncology. 1988 ; Vol. 6, No. 10. pp. 1576-1583.
@article{4acd3fdaabff407091568a106f2d52e9,
title = "Stage IA and IIA supradiaphragmatic Hodgkin's disease: Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation",
abstract = "A total of 315 pathologically staged (PS) patients with IA and IIA Hodgkin's disease (HD) were treated with mantle and paraaortic irradiation, and evaluated for freedom-from-first relapse (FFR), survival, prognostic factors, and long-term complications. The 14-year actuarial FFR and survival were 82{\%} and 93{\%}, respectively, with a median follow-up time of 9 years. Mediastinal size was the only factor that predicted for a lower FFR, P <.0001. Forty-nine patients have developed recurrent HD. Thirty-six patients are disease-free following retreatment and only 13 patients have died of HD. Patients with mixed cellularity (MC) histology were more likely to relapse below the diaphragm (11{\%}) as compared with patients with nodular sclerosis (NS) (5.1{\%}) or lymphocyte predominant (LP) (3.6{\%}) histology. These relapses were often associated with bulky pelvic nodal adenopathy, and salvage treatment with chemotherapy alone often failed to control recurrent disease. Alternative diagnostic and therapeutic recommendations are presented for three patients. Thyroid abnormalities represented the most common long-term complication with an actuarial risk at 16 years of 37{\%}. Major complications were rare. Mantle and paraaortic irradiation is associated with a high FFR and a low risk of complications and should remain standard treatment for early-stage HD.",
author = "P. Mauch and N. Tarbell and H. Weinstein and B. Silver and T. Goffman and R. Osteen and A. Zajac and Coleman, {C. N.} and G. Canellos and D. Rosenthal",
year = "1988",
language = "English (US)",
volume = "6",
pages = "1576--1583",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "10",

}

TY - JOUR

T1 - Stage IA and IIA supradiaphragmatic Hodgkin's disease

T2 - Prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation

AU - Mauch, P.

AU - Tarbell, N.

AU - Weinstein, H.

AU - Silver, B.

AU - Goffman, T.

AU - Osteen, R.

AU - Zajac, A.

AU - Coleman, C. N.

AU - Canellos, G.

AU - Rosenthal, D.

PY - 1988

Y1 - 1988

N2 - A total of 315 pathologically staged (PS) patients with IA and IIA Hodgkin's disease (HD) were treated with mantle and paraaortic irradiation, and evaluated for freedom-from-first relapse (FFR), survival, prognostic factors, and long-term complications. The 14-year actuarial FFR and survival were 82% and 93%, respectively, with a median follow-up time of 9 years. Mediastinal size was the only factor that predicted for a lower FFR, P <.0001. Forty-nine patients have developed recurrent HD. Thirty-six patients are disease-free following retreatment and only 13 patients have died of HD. Patients with mixed cellularity (MC) histology were more likely to relapse below the diaphragm (11%) as compared with patients with nodular sclerosis (NS) (5.1%) or lymphocyte predominant (LP) (3.6%) histology. These relapses were often associated with bulky pelvic nodal adenopathy, and salvage treatment with chemotherapy alone often failed to control recurrent disease. Alternative diagnostic and therapeutic recommendations are presented for three patients. Thyroid abnormalities represented the most common long-term complication with an actuarial risk at 16 years of 37%. Major complications were rare. Mantle and paraaortic irradiation is associated with a high FFR and a low risk of complications and should remain standard treatment for early-stage HD.

AB - A total of 315 pathologically staged (PS) patients with IA and IIA Hodgkin's disease (HD) were treated with mantle and paraaortic irradiation, and evaluated for freedom-from-first relapse (FFR), survival, prognostic factors, and long-term complications. The 14-year actuarial FFR and survival were 82% and 93%, respectively, with a median follow-up time of 9 years. Mediastinal size was the only factor that predicted for a lower FFR, P <.0001. Forty-nine patients have developed recurrent HD. Thirty-six patients are disease-free following retreatment and only 13 patients have died of HD. Patients with mixed cellularity (MC) histology were more likely to relapse below the diaphragm (11%) as compared with patients with nodular sclerosis (NS) (5.1%) or lymphocyte predominant (LP) (3.6%) histology. These relapses were often associated with bulky pelvic nodal adenopathy, and salvage treatment with chemotherapy alone often failed to control recurrent disease. Alternative diagnostic and therapeutic recommendations are presented for three patients. Thyroid abnormalities represented the most common long-term complication with an actuarial risk at 16 years of 37%. Major complications were rare. Mantle and paraaortic irradiation is associated with a high FFR and a low risk of complications and should remain standard treatment for early-stage HD.

UR - http://www.scopus.com/inward/record.url?scp=0024246669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024246669&partnerID=8YFLogxK

M3 - Article

C2 - 3171625

AN - SCOPUS:0024246669

VL - 6

SP - 1576

EP - 1583

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 10

ER -